A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-directed Therapy
Clinical trial NCT01419197 · COMPLETED
Trial details
- NCT number
- NCT01419197
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-02-01
- Enrollment
- 602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.